Prostate Cancer Screening in 2025: Are We There Yet?


At the conclusion of this activity, participants will be able to:

  1. Review the epidemiology and risk factors of prostate cancer.
  2. Discuss the evolution and impact of USPSTF recommendations on PSA Screening.
  3. Identify current biomarkers and guidelines for prostate cancer screening.